共 100 条
[1]
Schrappe M(2000)Long-term results of large prospective trials in childhood acute lymphoblastic leukemia Leukemia 14 2193-2194
[2]
Camitta B(1998)Meeting report: International childhood ALL workshop Leukemia 8 1313-1318
[3]
Pui CH(1996)Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia J Clin Oncol 1 18-24
[4]
Pui CH(2000)Normal and malignant hemopoiesis: spotlight on long-term results of pediatric ALL clinical trials from study 12 groups world wide Leukemia 14 2193-2320
[5]
Evans WE(2001)Inter-national Childhood Acute Lymphoblastic Leukemia Workshop Leukemia 15 707-715
[6]
Gilbert JR(2000)Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia N Engl J Med 342 998-1006
[7]
Smith M(2002)Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region Lancet 359 1909-1915
[8]
Arthur D(2002)Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987–1999 Br J Haematol 117 306-314
[9]
Camitta B(2000)Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group Br J Haematol 110 147-153
[10]
Carroll AJ(1998)Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia Leukemia 12 346-352